Blume Capital Management, Inc. Corcept Therapeutics Inc Transaction History
Blume Capital Management, Inc.
- $401 Million
- Q1 2024
Shares
2 transactions
Others Institutions Holding CORT
# of Institutions
316Shares Held
93.8MCall Options Held
2.02MPut Options Held
3.24M-
Black Rock Inc. New York, NY16.8MShares$513 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.57MShares$292 Million0.0% of portfolio
-
Ingalls & Snyder LLC New York, NY8.3MShares$253 Million9.24% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny7.12MShares$217 Million0.28% of portfolio
-
Parallel Advisors, LLC3.82MShares$116 Million2.62% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $3.27B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...